SciELO - Scientific Electronic Library Online

 
vol.141 número5Características clínicas y evolución de pacientes con SIDA y dolor abdominal agudoRadiocirugía estereotáxica con acelerador lineal (LINAC): Informe de la experiencia técnica en el manejo de 100 casos en el Hospital General de México índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

ARELLANES-GARCIA, Lourdes; PADILLA-AGUILAR, Gonzalo; NAVARRO-LOPEZ, Patricia  y  ESPINOZA-MARTINEZ, Cynthia. Efficacy of prednisolone and rimexolone in HLA-B27 positive patients with acute anterior uveitis. Gac. Méd. Méx [online]. 2005, vol.141, n.5, pp.363-366. ISSN 2696-1288.

Purpose: To compare the efficacy and safety of prednisolone acetate 1 % vs. rimexolone 1 % ophthalmic suspension in the treatment of acute anterior uveitis (AAU) in HLA-B27+ patients. Methods: Sixty-eight AAU HLA-B27+ patients were randomly selected for treatment with prednisolone acetate 1% or Rimexolone 1%. All patients showed mild to moderate anterior chamber inflammation. This was a prospective, randomized, double blind, clinical trial. Results: There was no statistically significant difference between both groups when anterior chamber cells were measured. In the rimexolone group, flare diminished since the first week. In both groups the intraocular pressure (IOP) raised since the first week; the increase washighly significant in the rimexolone group. Final intraocular pressure was higher in the prednisolone group. Conclusion: Rimexolone 1 % is as effective as prednisolone acetate 1% in the treatment of mild to moderate AAU HLA B27+. IOP increased in both groups, but this variation was not clinically significant.

Palabras llave : Anterior uveitis; flare; cells; rimexolone; prednisolone acetate; HLA-B27; intraocular pressure.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons